These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16821338)

  • 21. [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].
    Roche JB; Malavaud B; Soulié M; Cournot M; Gamé X; Mazerolles C; Bachaud JM; Plante P; Rischmann P
    Prog Urol; 2008 Oct; 18(9):586-94. PubMed ID: 18986631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.
    Secin FP; Serio A; Bianco FJ; Karanikolas NT; Kuroiwa K; Vickers A; Touijer K; Guillonneau B
    Eur Urol; 2007 Mar; 51(3):764-71. PubMed ID: 17098356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PSA and follow-up after treatment of prostate cancer].
    Benchikh El Fegoun A; Villers A; Moreau JL; Richaud P; Rebillard X; Beuzeboc P
    Prog Urol; 2008 Mar; 18(3):137-44. PubMed ID: 18472065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of the positive surgical margin following radical prostatectomy.
    Yang Y
    Chin Med J (Engl); 2008 Feb; 121(4):375-9. PubMed ID: 18304473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
    BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR; Yu X; Loeb S; Desireddi VN; Han M; Graif T; Catalona WJ
    J Urol; 2007 Sep; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.
    Boorjian SA; Karnes RJ; Crispen PL; Rangel LJ; Bergstralh EJ; Sebo TJ; Blute ML
    J Urol; 2009 Jan; 181(1):95-104; discussion 104. PubMed ID: 19012937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative PSA is still predictive of cancer volume and grade in late PSA era.
    Figler BD; Reuther AM; Dhar N; Levin H; Magi-Galluzzi C; Zhou M; Klein EA
    Urology; 2007 Oct; 70(4):711-6. PubMed ID: 17991542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological approach to prostatic contour alterations with the concept of left-right asymmetry.
    Kiyoshima K; Oda Y; Tamiya S; Hori Y; Yamada T; Naito S; Tsuneyoshi M
    Pathol Int; 2006 Jul; 56(7):390-6. PubMed ID: 16792548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
    Khatami A; Hugosson J; Wang W; Damber JE
    Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer volume at biopsy predicts clinically significant upgrading.
    Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA
    J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
    Osunkoya AO; Nielsen ME; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
    Macdonald OK; Lee RJ; Snow G; Lee CM; Tward JD; Middleton AW; Middleton GW; Sause WT
    Urology; 2007 Feb; 69(2):295-9. PubMed ID: 17320667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins.
    Trabulsi EJ; Linden RA; Gomella LG; McGinnis DE; Strup SE; Lallas CD
    Can J Urol; 2008 Apr; 15(2):3994-9. PubMed ID: 18405448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of persistently detectable PSA after radical prostatectomy.
    Naselli A; Introini C; Andreatta R; Spina B; Truini M; Puppo P
    Int J Urol; 2009 Jan; 16(1):82-6. PubMed ID: 19054168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of positive surgical margins after radical perineal prostatectomy.
    Goetzl MA; Krebill R; Griebling TL; Thrasher JB
    Can J Urol; 2009 Apr; 16(2):4553-7. PubMed ID: 19364427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer.
    Merrill MM; Lane BR; Reuther AM; Zhou M; Magi-Galluzzi C; Klein EA
    Urology; 2007 Aug; 70(2):294-8. PubMed ID: 17826492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL
    Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
    Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.